| Literature DB >> 31440455 |
A Baradaran1, F Samadi1, S S Ramezanpour2, S Yousefdoust1.
Abstract
This study was conducted to investigate the hepatoprotective effects of silymarin on CCl4-induced oxidative stress in broiler chickens model. A total of 240 day-old broilers were divided into 4 equal groups (n = 60) composed of a control group (receiving 1 mL/Kg BW saline) and 3 groups treated with silymarin (receiving 100 mg/Kg BW silymarin), CCl4 (receiving 1 mL/Kg BW CCl4), and combination of silymarin + CCl4. Results indicated that silymarin has potential to mitigate the deleterious effects of CCl4 on protein and lipid metabolism. The protective activity of silymarin against CCl4-mediated lipid peroxidation was demonstrated by the lower serum content of MDA, as lipid peroxidation marker. CCl4-induced hepatotoxicity was demonstrated by the elevation of serum contents of ALP, AST, ALT, and GGT enzymes, whereas silymarin decreased serum activity of ALP and AST hepatic enzymes. The CCl4-challenged birds revealed considerable hepatic injures characterized by moderate to severe hepatocellular degeneration around the portal vein, aggregation of inflammatory cells, granulomatosis, cytolytic necrosis, periportal space fibrosis, and sinusoidal dilatation. However, liver damages were amended by the silymarin. In line with molecular study, a remarkable down-regulation was detected in the expression of CAT, GPx, and Mn-SOD hepatic genes in CCl4-challenged birds, whereas silymarin significantly up-regulated aforementioned genes. In general, current study showed that silymarin has potential to alleviate the adverse effects of oxidative stress in poultry farms.Entities:
Keywords: Broiler chickens; CCl4; Gene expression; Oxidative stress; Silymarin
Year: 2019 PMID: 31440455 PMCID: PMC6698800 DOI: 10.1016/j.toxrep.2019.07.011
Source DB: PubMed Journal: Toxicol Rep ISSN: 2214-7500
Primers of CAT, Mn-SOD, GPx, and β-actin for real-time PCR1.
| Objective | Accession | Primer sequence (5′ to 3′) | Annealing temperature (°C) | Amplicon |
|---|---|---|---|---|
| CAT | NM_001031215.2 | Forward: CTTTCCCTCTTCCCTTACCA | 58.24 | 182 |
| Reverse: GGTAGTAGCTGGGCTCTGAAA | 58.62 | |||
| Mn-SOD | AF299388.1 | Forward: ACAGATAGCAGCCTGTGCAA | 59.62 | 163 |
| Reverse: CGCGTTCTCCCAGTTGAT | 59.79 | |||
| GPX | U22046.1 | Forward: GACGGCTGAGAGTTGATCCT | 59.41 | 176 |
| Reverse: CTGCGGGTATTTGATGTCC | 58.94 | |||
| β-actin | NM_205518.1 | Forward: AGTTACTCGCCTCTGTGAAGG | 94.59 | 198 |
| Reverse: CACATCTATCACTGGGGAACAC | 33.59 |
1CAT: Catalase; Mn-SOD: Manganese super oxide dismutase; GPX: Glutathione peroxide1; β-actin: Internal control.
Results of HPLC analysis of silymarin.
| Item | Content (%) |
|---|---|
| Taxifolin | 6.44 |
| Silychristin | 24.51 |
| Silydianin | 7.60 |
| Silybin A1 | 24.81 |
| Silybin B1 | 26.72 |
| Isosilybin A | 4.21 |
| Isosilybin B | ND2 |
1Silybins A and B are two diastereomers of silibinin (silybin).
2Not detectable.
Effects of experimental treatments on blood serum biochemical at 42 d of age in broiler chickens.
| Experimental | Total | Albumin | Glucose | Total cholesterol | Triglyceride | LDL-c1 | HDL-c2 |
|---|---|---|---|---|---|---|---|
| Control | 3.49a | 1.71a | 226.06 | 113.16b | 36.95b | 17.22b | 88.51 |
| Silymarin | 3.36a | 1.76a | 221.21 | 111.48b | 33.51b | 14.15b | 90.72 |
| CCl4 | 2.51b | 1.40b | 213.28 | 119.96a | 44.12a | 26.97a | 83.54 |
| Silymarin × CCl4 | 3.19a | 1.62a | 208.90 | 122.05a | 35.59b | 19.51b | 95.52 |
| SEM | 0.15 | 0.07 | 3.40 | 2.68 | 2.42 | 2.25 | 2.57 |
a-c means within a column with different superscript differ significantly (P < 0.05).
1LDL-c, low density lipoprotein cholesterol; 2HDL-c, high density lipoprotein cholesterol.
Effects of experimental treatments on blood serum oxidative biomarkers (MDA, TAC and LDH) at 42 d of age in broiler chickens.
| Experimental | MDA1 (nmol/mL) | TAC2 (U/mL) | LDH3 (U/L) |
|---|---|---|---|
| Control | 1.37c | 1.95a | 93.42b |
| Silymarin | 1.62ac | 1.86a | 100.36ab |
| CCl4 | 2.23a | 1.20b | 108.54a |
| Silymarin × CCl4 | 1.87ab | 1.35b | 109.45a |
| SEM | 0.12 | 0.12 | 4.31 |
a-c means within a column with different superscript differ significantly (P < 0.05).
1MDA, Malondialdehyde; 2TAC, Total antioxidant capacity; 3LDH, Lactate dehydrogenase.
Effects of experimental treatments on the blood serum activity of hepatic enzymes (ALP, AST, ALT, and GGT) at 42 d of age in broiler chickens.
| Experimental treatments | ALP1 | AST2 | ALT3 | GGT4 |
|---|---|---|---|---|
| Control | 203.41c | 221.25b | 6.65b | 10.22b |
| Silymarin | 225.18b | 225.91b | 7.28ab | 10.85b |
| CCl4 | 262.28a | 236.56a | 8.39a | 12.61a |
| Silymarin × CCl4 | 232.65b | 227.03ab | 8.15a | 11.46ab |
| SEM | 14.19 | 2.44 | 0.34 | 0.41 |
a-c means within a column with different superscript differ significantly (P<0.05).
1ALP, Alkaline phosphatase; 2AST, Aspartate aminotransferase; 3ALT, Alanine aminotransferease; 4GGT, Gamma-glutamyl transferase.
Hepatic histopathological changes in broiler chickens treated by experimental treatments.
| Items | Control | CCl4 | Silymarin | CCl4 × Silymarin |
|---|---|---|---|---|
| Inflammation | – | +++ | – | – |
| Granulomatosis | – | + | + | + |
| Cytolytic necrosis | – | +++ | – | + |
| Periportal space fibrosis | – | ++ | + | + |
| Cellular degeneration | – | +++ | – | + |
| Sinusoidal dilatation | – | +++ | – | – |
(-) No histopathologic change, (+) histopathology in <20% of fields, (++) histopathology in 20–60% of fields, and (+++) histopathology in >60% of fields.
Fig. 1Photomicrographs of the liver portal triad histopathology in broiler chicks administrated by experimental treatments. A: Control, B: CCl4, C: Silymarin, D: Silymarin + CCl4. Branch of portal vein (PV), branch of portal artery (arrowheads) and branch of bile duct (arrow). Magnification of 20×.
Fig. 2The catalase (CAT), glutathione peroxidase (GPx), and manganese-superoxide dismutase (Mn-SOD) relative mRNA expression in the liver of broiler chickens. * P < 0.05, ** P < 0.01 when comparing with the control.